Succinate drives macrophage inflammation by promoting GPR91 mitochondrial signaling in rheumatoid arthritis
Science Translational Medicine · 12.08.2026 · 18 (862)
DOI: 10.1126/scitranslmed.aea8468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 12.08.2026. Verfasst von Wankang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, School of Pharmacy; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Medical…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Receptors, G-Protein-Coupled, Mitochondria, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Provincial, Young Elite Scientists Sponsorship Program by Anhui Association for Science and Technology.
Abstract (Originalsprache)
High succinate concentrations are implicated in rheumatoid arthritis (RA) and other inflammatory diseases through G protein–coupled receptor 91 (GPR91)–mediated signaling. Despite the therapeutic potential of targeting GPR91, conflicting reports on the receptor’s inflammatory roles have hindered treatment development. Here, we report that the effects of succinate on GPR91 signaling are biphasic and concentration dependent. At physiological succinate concentration, membrane-localized GPR91 promotes M2 polarization through G q -mediated activation of phospholipase C and intracellular calcium mobilization. In RA, elevated succinate induces GPR91 internalization and mitochondrial translocation, thereby disrupting G q signaling. Mechanistically, mitochondrial GPR91 recruits G s proteins and, together with intracellular succinate, activates the cyclic adenosine monophosphate (cAMP)–protein kinase A (PKA) pathway. PKA then phosphorylates cytidine/uridine monophosphate kinase 2 at serine-404, stabilizing it to enhance mitochondrial DNA (mtDNA) synthesis. Newly synthesized mtDNA is oxidized (forming ox-mtDNA) and released into the cytosol, activating the cyclic GMP-AMP synthase–stimulator of interferon genes pathway to drive macrophage inflammation. Myeloid-specific GPR91 deletion or inhibition of intracellular succinate accumulation alleviates arthritis in mice. This study reveals that GPR91 reprograms signaling by subcellular relocation, providing a promising therapeutic strategy for autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Pharmacology, School of Pharmacy; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei 230032, China.
- Department of Clinical Pharmacology, Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
ORCID-Profile: Wankang Zhang, Luping Wang, Yingjie Zhao, Yao Mu, Lei Qiu, Xinyu Feng, Yueye Wang, Jiemin Zhao, Yan Chang, Wei Wei, Xuezhi Yang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Provincial
- Young Elite Scientists Sponsorship Program by Anhui Association for Science and Technology
Zitieren
APA
Zhang, W., Wang, L., Zhao, Y., Mu, Y., Qiu, L., Feng, X., Wang, Y., Zhao, J., Chang, Y., Wei, W., & Yang, X. (2026). Succinate drives macrophage inflammation by promoting GPR91 mitochondrial signaling in rheumatoid arthritis. Science Translational Medicine, 18(862). https://doi.org/10.1126/scitranslmed.aea8468
Vancouver
Zhang W, Wang L, Zhao Y, Mu Y, Qiu L, Feng X, et al. Succinate drives macrophage inflammation by promoting GPR91 mitochondrial signaling in rheumatoid arthritis. Science Translational Medicine. 2026;18(862). doi:10.1126/scitranslmed.aea8468
BibTeX
@article{Zhang2026,
author = {Zhang, Wankang and Wang, Luping and Zhao, Yingjie and Mu, Yao and Qiu, Lei and Feng, Xinyu and Wang, Yueye and Zhao, Jiemin and Chang, Yan and Wei, Wei and Yang, Xuezhi},
title = {Succinate drives macrophage inflammation by promoting GPR91 mitochondrial signaling in rheumatoid arthritis},
journal = {Science Translational Medicine},
year = {2026},
volume = {18},
number = {862},
doi = {10.1126/scitranslmed.aea8468}
}
EUVIMED